GE HealthCare Technologies Inc. - Common Stock (GEHC)
70.26
+0.53 (0.76%)
NASDAQ· Last Trade: Aug 4th, 7:46 PM EDT
Detailed Quote
Previous Close
69.73
Open
69.47
Bid
69.50
Ask
70.80
Day's Range
68.85 - 70.36
52 Week Range
58.75 - 89.77
Volume
3,427,465
Market Cap
31.90B
PE Ratio (TTM)
14.52
EPS (TTM)
4.8
Dividend & Yield
0.1400 (0.20%)
1 Month Average Volume
5,879,091
Chart
About GE HealthCare Technologies Inc. - Common Stock (GEHC)
GE HealthCare Technologies Inc. is a leading global medical technology and digital solutions innovator focused on improving patient outcomes through advanced healthcare solutions. The company develops and manufactures a wide range of diagnostic imaging systems, monitoring devices, and healthcare IT services that empower healthcare providers to deliver accurate and efficient patient care. Through its commitment to innovation, GE HealthCare supports clinicians and patients by providing tools that enhance diagnostic capabilities, streamline workflows, and facilitate data-driven decision-making in an increasingly complex healthcare environment. Read More
GE HealthCare today announced the introduction of the LOGIQ™ e family, featuring LOGIQ™ e Xi and LOGIQ™ e Si, two compact laptop ultrasound systems designed to help clinicians deliver simple, fast, and confident ultrasound imaging where it’s needed across care settings.ii Building on the legacy of LOGIQ e, the LOGIQ e family pairs a reliable console-level performance with a compact, intuitive design combining AI-powered featuresiii and workflow tools that support portability and flexibility for care beyond traditional imaging departments.
GE HealthCare today announced the launch of Invenia™ ABUS (Automated Breast Ultrasound) Prime and ABUS StreamVue™, a redesigned enterprise viewer that recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, expanding its breast imaging portfolio with solutions designed to support supplemental screening for women with dense breasts and provide more flexible enterprise-wide exam review. Together, these new solutions aim to help breast imaging programs standardize 3D ultrasound acquisition, support remote reading, and simplify deployment across multi-site networks.
GE HealthCare posted strong Q2 results with record backlog and book-to-bill, while reviewing a possible sale of its underperforming Patient Care Solutions segment.
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5...
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...
What Happened? Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) jumped 11% in the afternoon session after the company reporte...
GE HealthCare Technologies (NASDAQ:GEHC) reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issu
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 5.8% ...
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings this Wednesday before market open. Here’s what investors sh...
Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has appointed George Newcomb, currently Controller and Chief Accounting Officer, as interim Chief Financial Officer. Mr. Saccaro will remain with the Company through August 14, 2026, and work together with Mr. Newcomb to ensure a smooth transition. GE HealthCare has commenced a search for a permanent successor.
